Key Segmentation
By Product
-
Instruments
-
Consumables and Reagents
By Sample Type
-
Blood Culture
-
Whole Blood
-
Plasma
-
Serum
-
Other Body Fluids
By Technology
-
Microbiological Testing/Culture-Based
-
Molecular Diagnostics
-
Immunoassays
-
Mass Spectrometry
By Test Type
-
Conventional Blood Culture Tests
-
PCR Method
-
Nucleic Acid Testing
-
Mass Spectrometry Testing
-
Point-of-Care Testing
By End User
-
Hospitals
-
Diagnostic Laboratories
-
Ambulatory Care Centers
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Rising hospital-acquired bloodstream infection incidence creating consistent diagnostic testing procurement.
The Bloodstream Infection Testing Market is expected to grow at a CAGR of 4.80% from 2026 to 2035.
The Bloodstream Infection Testing Market was valued at USD 876.49 Million in 2025.
North America dominated the Bloodstream Infection Testing Market in 2025.
Blood Culture dominated the Bloodstream Infection Testing Market with approximately 78.8% share in 2025.